Literature DB >> 14978695

Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course.

Uzair B Chaudhary1, Stephen F Eberwine, Kristen M Hege.   

Abstract

Acquired amegakaryocytic thrombocytopenia purpura (AATP) is a rare disorder of unclear etiology characterized by severe thrombocytopenia, preservation of erythroid and myeloid cell lines, and absence of megakaryocytes in the bone marrow. We report herein a patient who developed eosinophilic fasciitis preceding a diagnosis of AATP. Longitudinal follow-up and treatment of this individual show a relapsing and remitting disease course which appears closely related to the dosing of cyclosporine. Later in the treatment course, dosing of anti-thymocyte globulin (ATG) appeared to have important beneficial contributions in the management of this patient's disease. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978695     DOI: 10.1002/ajh.10475

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

1.  Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still's disease.

Authors:  Min-Young Her; Tae-Hwan Kim; Hyun-Kyu Chang; Woong-Soo Lee; Dae-Hyun Yoo
Journal:  Rheumatol Int       Date:  2006-09-07       Impact factor: 2.631

2.  Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up.

Authors:  Mehrzad Mirzania; Sedigheh Khalili; Akbar Hasanpoor; Ahmad Reza Shamshiri
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

Review 3.  Eosinophilic fasciitis during pregnancy: case report and review of literature.

Authors:  Maria Ester Simeira Fonseca; Maria Victória Quaresma; Ana Paula Luppino-Assad; Henrique Carriço da Silva; Danieli Castro O Andrade; Percival D Sampaio-Barros
Journal:  Rheumatol Int       Date:  2017-12-15       Impact factor: 2.631

4.  Good response to cyclosporin in a child with acquired thrombocytopenic purpura.

Authors:  Shuchita Jain; Seema Kapoor; Ankur Singh; R N Mandal Ravi; Silky Jain
Journal:  Indian J Pediatr       Date:  2011-12-15       Impact factor: 5.319

5.  Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.

Authors:  Takanori Ichikawa; Yasuhiro Shimojima; Toshiaki Otuki; Ken-Ichi Ueno; Dai Kishida; Yoshiki Sekijima
Journal:  Intern Med       Date:  2019-08-06       Impact factor: 1.271

Review 6.  Anti Thymocyte Globulin-Based Treatment for Acquired Bone Marrow Failure in Adults.

Authors:  Jennifer M-L Tjon; Saskia M C Langemeijer; Constantijn J M Halkes
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

Review 7.  Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome.

Authors:  Yukie Endo; Atsushi Tamura; Youichiro Matsushima; Tomoko Iwasaki; Michiko Hasegawa; Yayoi Nagai; Osamu Ishikawa
Journal:  Clin Rheumatol       Date:  2007-03-08       Impact factor: 3.650

8.  "Almost bleeding to death": the conundrum of acquired amegakaryocytic thrombocytopenia.

Authors:  Gabrielle Elena Brown; Hani M Babiker; Carlos L Cantu; Andrew M Yeager; Ravitharan Krishnadasan
Journal:  Case Rep Hematol       Date:  2014-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.